Citation: Am. Kechli et al., FACTOR-V-LEIDEN (FVL) IS NOT ASSOCIATED WITH OSTEONECROSIS DEVELOPINGDURING TREATMENT OF PEDIATRIC CANCERS, Journal of investigative medicine, 46(1), 1998, pp. 11-11
Citation: Am. Kechli et al., PREVALENCE OF FACTOR-V-LEIDEN IN PATIENTS WITH LEGG-PERTHES DISEASE, Journal of investigative medicine, 46(1), 1998, pp. 11-11
Citation: Sr. Deitcher et al., EFFECT OF INTERMEDIATE-PURITY AND HIGH-PURITY FACTOR-VIII CONCENTRATES ON IMMUNE FUNCTION IN HIV-SEROPOSITIVE HEMOPHILIACS AS ASSESSED BY QUANTITATIVE CD-4 COUNTS, Haemophilia, 3(4), 1997, pp. 265-269
Authors:
BELGAUMI AF
PATRICK CC
TONKEL S
DEITCHER SR
JUDE S
Citation: Af. Belgaumi et al., STABILITY AND STERILITY OF A RECOMBINANT FACTOR-VIII CONCENTRATE (BIOCLATE(TM)) PREPARED FOR CONTINUOUS-INFUSION PROPHYLAXIS, Thrombosis and haemostasis, 1997, pp. 2092-2092
Citation: Sr. Deitcher et J. Gardner, UTILITY OF THE INTERNATIONAL NORMALIZED RATIO (INR) IN PATIENTS WITH LIVER-DISEASE, Thrombosis and haemostasis, 1997, pp. 2538-2538
Authors:
DEITCHER SR
TULLER J
HANNA W
ZIMMERMAN C
WILIAMS J
Citation: Sr. Deitcher et al., ATTENUATION OF A HIGH-RESPONDING FACTOR-VIII INHIBITOR IN A CHILD WITH HEMOPHILIA FOLLOWING CHEMOTHERAPY FOR ACUTE-LEUKEMIA, Thrombosis and haemostasis, 1997, pp. 2645-2645
Authors:
WILLNER IR
WATERS B
PAYTON JD
DEITCHER SR
LEVINSON MJ
RIELY CA
Citation: Ir. Willner et al., HEPATOPORTAL SCLEROSIS - CLINICAL-FEATURES AND ASSOCIATION WITH HYPERCOAGULABLE STATES, Hepatology, 26(4), 1997, pp. 302-302
Citation: Sr. Deitcher et al., ACQUIRED FREE PROTEIN-S DEFICIENCY ASSOCIATED WITH MULTIPLE-MYELOMA -A CASE-REPORT, American journal of hematology, 51(4), 1996, pp. 319-323
Citation: Sa. Limentani et al., IN-VITRO CHARACTERIZATION OF HIGH-PURITY FACTOR-IX CONCENTRATES FOR THE TREATMENT OF HEMOPHILIA-B, Thrombosis and haemostasis, 73(4), 1995, pp. 584-591
Citation: Kj. Kotkow et al., THE 2ND KRINGLE DOMAIN OF PROTHROMBIN PROMOTES FACTOR VA-MEDIATED PROTHROMBIN ACTIVATION BY PROTHROMBINASE, The Journal of biological chemistry, 270(9), 1995, pp. 4551-4557
Citation: Sr. Deitcher et al., EFFECT OF INTERMEDIATE-PURITY AND HIGH-PURITY FACTOR-VIII CONCENTRATES ON IMMUNE FUNCTION IN HIV-SEROPOSITIVE HEMOPHILIACS AS ASSESSED BY QUANTITATIVE CD4 COUNT, Blood, 86(10), 1995, pp. 2219-2219
Citation: Pa. Herring et al., IN-VITRO EFFECT OF L-ASPARAGINASE (L-ASP) ON COAGULATION-FACTORS AND NATURAL ANTICOAGULANT PROTEINS, Blood, 86(10), 1995, pp. 3037-3037
Citation: Sa. Limentani et al., HIGH-PURITY FACTOR-IX CONCENTRATES FOR TREATMENT OF HEMOPHILIA-B - RELATIVE PURITY AND THROMBOGENIC POTENTIAL, Acta haematologica, 94, 1995, pp. 12-17
Citation: Sr. Deitcher et al., ROLE OF ARGININE-9 AND ARGININE-15 IN THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAIN OF HUMAN PROTHROMBIN IN MEDIATING BINDING TO ACIDIC PHOSPHOLIPID-VESICLES, Blood, 84(10), 1994, pp. 10000532-10000532
Citation: Sr. Deitcher et al., IMPAIRED RESOLUTION OF MASSIVE PULMONARY-EMBOLISM ASSOCIATED WITH AN INHIBITED FIBRINOLYTIC RESPONSE, The American journal of medicine, 96(5), 1994, pp. 483-484
Citation: L. Daley et al., UROKINASE RESOLUTION OF IMPENDING PARADOXIC EMBOLUS IN TRANSIT - EVALUATION BY MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY, The American heart journal, 128(6), 1994, pp. 1239-1241